CFTR and cystic fibrosis: When CF human bronchial primary epithelial cells (HBEC) were treated with lumacaftor, 25% of the ion transport of p.F508del-CFTR was rescued, and, even if the rate of fluid re-absorption was not modified, this functional correction was enough to reduce significantly the ASL mucus viscosity [13].